Novo exits Hims & Hers partnership, citing deceptive marketing concerns
Novo Nordisk A/S scrapped a partnership with Hims & Hers Health Inc. after less than two months, saying the US…
42,230€
4,45%
Echtzeit-Aktienkurs Hims & Hers Health Inc.
Bid:
Ask:
Nachrichten zur Hims & Hers Health Inc. Aktie
Novo Nordisk ends Hims & Hers partnership over GLP-1 safety concern...
Novo Nordisk terminated its collaboration with telehealth provider Hims & Hers over allegations of deceptive promotion of non-FDA-approved semaglutide alternatives.…
Novo Nordisk pulls out of deal with Hims & Hers
Danish diabetes and obesity giant Novo Nordisk yesterday announced that it will no longer be working with Hims & Hers…
Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug
Novo Nordisk has ended a partnership with the telehealth company that lasted less than two months.…
Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Heres What Investors Need to Know
On April 29, Novo Nordisk (NYSE: NVO) and Hims & Hers Health (NYSE: HIMS) announced they were collaborating to allow…
Hims & Hers Health Aktie im freien Fall - Rechtlicher Ärger um Wegovy
Frankfurt (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse von XTB:
Jeremy Krings, Junior Marktanalyst bei XTB in Deutschland, nimmt die Aktie von…
Hims & Hers-Aktie stürzt ab: Novo Nordisk beendet Zusammenarbeit abrupt
Am Montagmorgen untersagte Novo Nordisk Hims & Hers Health den Verkauf des günstigeren Wegovy-Präparats. Die Erklärung für diese abrupte Entscheidung,…
Tesla startet Robotaxi-Dienst - Novo Nordisk beendet Partnerschaft mit Hims & Hers
Wien (www.aktiencheck.de) - Der Elektroautobauer Tesla (+8,2%) startete den von Firmenchef Elon Musk seit langem angekündigten Robotaxi-Dienst - allerdings zunächst…
Märkte am Morgen: Waffenruhe sorgt für Kauflust! TUI, IBM, Hims & Hers, Nike, Tesla, Super Micro Computer
Die über Nacht von Präsident Trump angekündigte Waffenruhe zwischen dem Iran und Israel sorgt für neue Euphorie an den Märkten.…
Wegovy-maker Novo Nordisk abruptly ends partnership with Hims & Hers
The drugmaker claimed that the telehealth company is illegally selling non-FDA approved weight-loss drugs.…
Hims & Hers stock plunges after Novo Nordisk ends its brief partnership
The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its…
Novo Nordisk drops Wegovy collaboration with Hims & Hers, alleges unsafe tactics
Novo Nordisk has cut ties with Hims & Hers Health, alleging that the latter company has engaged in deceptive marketing…
Hims & Hers Health, Inc. Shareholders Who Lost Money on Their Investment are Encouraged to Contact Johnson Fistel about the Class Action Investigation
SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that it is investigating potential claims…
HIMS INVESTIGATION NOTICE: Hims & Hers Health, Inc. is being Investigated for Securities Fraud– Investors are Notified to Contact BFA Law (NYSE:HIMS)
Hims & Hers Health, Inc. investors that lost money are notified to contact BFA Law about its ongoing securities fraud…
Kirby McInerney LLP Announces Investigation Against Hims & Hers Health, Inc. (HIMS) on Behalf of Investors
NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential…
HIMS INVESTIGATION ALERT: Investigation Launched into Hims & Hers Health, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm
/PRNewswire/ -- Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Hims &…
HIMS & HERS HEALTH INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims on Behalf of Investors of Hims & Hers Health, Inc.
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick &…
HIMS BREAKING NEWS: Hims & Hers Health, Inc. is being Investigated for Securities Fraud; Investors with Losses are Notified to Contact BFA Law
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Hims & Hers Health, Inc. (NYSE: HIMS)…
Hims & Hers Health, Inc. (HIMS) Stock Declines While Market Improves: Some Information for Investors
Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $41.98, signifying a -34.63% move from its prior…
Hims & Hers CEO No Longer A Billionaire After Novo Nordisk Deal Collapses
The fortune of the San Francisco-based telehealth company’s cofounder and chief executive, Andrew Dudum, crumbled by more than $400 million…
Hims & Hers stock plunges after Novo Nordisk ends Wegovy direct sales deal
Novo Nordisk ends deal with Hims & Hers over compounded GLP-1 sales.…
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 34%
Novo Nordisk said Hims & Hers has "failed to adhere to the law which prohibits mass sales of compounded drugs"…
Novo Nordisk Just Axed Its Deal with Hims & Hers. Should You Buy the Dip in HIMS Stock?
Hims & Hers stock tumbles as Novo Nordisk terminates Wegovy deal. BofA warns of significant further downside in the HIMS…
Hims & Hers stock plummets after Novo Nordisk ends partnership over "knock-off" Wegovy
It’s been a volatile ride for Hims stock price, which is now tumbling after partnership fallout.…
Kurssturz bei Hims & Hers und Novo Nordisk: Warum der Wegovy-Deal geplatzt ist – Analysten schlagen Alarm
Bad Marienberg (www.aktiencheck.de) -
Kurssturz bei Hims & Hers und Novo Nordisk: Warum der Wegovy-Deal
geplatzt ist – Analysten schlagen Alarm
Kurssturz…
Novo Nordisk ends partnership with Hims & Hers over Wegovy copycats
Drugmaker Novo Nordisk said it is halting its agreement with telehealth company Hims & Hers after less than two months, citing…
Securities Fraud Investigation Into Hims & Hers Health, Inc. (HIMS) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Hims & Hers Health, Inc. (“Hims” or the “Company”)…
Stocks making the biggest moves midday: Tesla, Novo Nordisk, Hims & Hers, Northern Trust, Fiserv and more
These are the stocks posting the largest moves in midday trading.…
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hims & Hers Health, Inc.…
Novo Nordisk halts Wegovy deal with Hims & Hers, triggering 31% stock drop
The companies had announced a collaboration in April for Hims & Hers to sell Novos Wegovy through an offering on…
Hims & Hers taumelt - Novo Nordisk beendet Partnerschaft
Die Aktionäre von Hims & Hers Health müssen am Montag einen herben Rückschlag verkraften. Novo Nordisk hat die Partnerschaft beendet.…
Novo–Hims & Hers deal ends, Eli Lilly GLP-1 pill: What to know
Hims & Hers (HIMS) stock is nosediving after Novo Nordisk (NVO) ended its deal with the company over continued sales…
Novo Nordisk ends collab with Hims & Hers over compound drug concerns
Novo Nordisk said Hims & Hers had failed to follow the law and accused the company of deceptive marketing.…
Novo Nordisk ends Hims & Hers tie-up over copycat Wegovy drugs
Shares in two companies slide as Danish drugmaker accuses US telehealth group of deceptively marketing replica treatments…
Rosen Law Firm Encourages Hims & Hers Health, Inc. Investors to Inquire About Securities Class Action Investigation
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of…
Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices
…
Hims & Hers stock plunges 30% as Novo Nordisk terminates Wegovy direct sales deal
Hims & Hers stock plunged around 30% on Monday after drugmaker Novo Nordisk abruptly ended a month-long collaboration to make…
Novo Nordisk ends collaboration with Hims & Hers
Novo Nordisk said its ending its collaboration due to concerns with Hims & Hers the companys sales and promotion of…
Hims & Hers stock plummets after Novo Nordisk ends Wegovy direct sales deal
Novo Nordisk ends deal with Hims & Hers over compounded GLP-1 sales.…
Hims & Hers, healthcare stocks, BNY: Trending Tickers
Novo Nordisk (NVO) ended its weight-loss drug partnership with Hims & Hers (HIMS), sending shares of both companies lower. UnitedHealth…
Hims & Hers stock drops after Wegovy manufacturer ends deal to distribute weight loss drug
Hims & Hers had partnered with the Danish pharmaceutical giant in April to sell Wegovy…
Hims & Hers stock falls after healthcare company cuts ties
NEW YORK (PIX11) — Hims & Hers stock has fallen nearly 30% on Monday after Novo Nordisk announced it is…
Hims & Hers Health (HIMS) Stock Trades Down, Here Is Why
What Happened?Shares of telehealth company Hims & Hers Health NYSE:HIMS fell 29.2% in the morning session after Novo Nordisk, the…
Hims & Hers Health (HIMS) Stock Trades Down, Here Is Why
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 29.2% in the morning session after Novo Nordisk, the maker…
Market movers: Tesla, Him & Hers, Circle...
…
Novo Nordisk (NVO) Ends Partnership with Hims & Hers Health Amid Safety Concerns
Novo Nordisk (NVO) shares decline after ending collaboration with Hims & Hers Health (HIMS). Analysts forecast a…
Why Did HIMS Shares Crash Today? Novo Nordisk Terminates Deal Over "Deceptive" Practices
Novo Nordisk ended its month-old partnership with Hims & Hers Health over illegal drug compounding practices.…
Plainsboro-Based Wegovy Provider Ends Hims & Hers Deal Over Knockoff Weight-Loss Drug Sales
Novo Nordisk has ended its partnership with Hims & Hers Health after two months, accusing the telehealth company of pushing…
Hims & Hers Stock (HIMS) Collapses 30% After Novo Nordisk Pulls Wegovy Deal on Safety Fears
Shares in telehealth group Hims Hers ($HIMS) shed 30% today after pharmaceuticals giant Novo Nordisk ($NVO) ended its collaboration…
Novo Severs Ties with Hims & Hers
Novo Nordisk (NYSE:NVO) shares tanked Monday, on word that the company will no longer be working with Hims & Hers…